Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

AI-Assisted Basal Cell Carcinoma Analysis in Line-Field Confocal OCT: Exploring Diagnostic Metrics.

Created on 14 Oct 2026

Authors

Otto Dideriksen, Kevin Jacobsen, Gavrielle R Untracht, Peter Alshede Philipsen, Merete Haedersdal, Vinzent Kevin Ortner

Published in

Journal of biophotonics. Volume 19. Issue 10. Pages e70374.

Abstract

Artificial Intelligence (AI)-assisted line-field confocal optical coherence tomography (LC-OCT) may support the clinical diagnosis of basal cell carcinoma (BCC). The current model produces frame-level BCC scores (0%-100%), but interpretation is challenging due to false positive frames. We present two novel scan-level metrics: the composite score (percentage of frames scoring 100% per scan) and the stability score (longest sequence of consecutive 100%-score-frames per scan). LC-OCT videos (n = 568) from 82 lesions from 52 patients were analyzed, including 18 BCCs and 64 non-BCCs. Both scores were significantly higher for BCCs than for non-BCCs (p < 0.0001). An exploratory threshold of 48 consecutive frames with 100% AI scores yielded 100% sensitivity (95% CI: 81.5%-100%) and 100% specificity (95% CI: 94.4%-100%). In conclusion, scan-level composite and stability scores demonstrate consistent separation between BCC and non-BCC lesions; however, external validation in independent cohorts is required before clinical implementation.

PMID:
42869100
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement